Table S10.
Sample size, mixed-effects model parameters, and estimated effects for data presented in Fig. 3G, β-galactosidase activity at attP40
| Sample size | Random effects | Fixed effects | Planned comparisons | ||||||||||||
| Day reps | Construct | N (lines) | Vials per line | Total samples | SD | Unequal variance multiplier | Estimate | SE | t value | df | P | ||||
| 4 | Single | 4 | 3 | 96 | Day | 2.82 | Single | 1 | (Intercept) | 99.61 | 2.91 | (Dup – Single) vs. Single | 6.90 | 6 | 0.00046 |
| Dup | 4 | 3 | 96 | Line | 4.23 | Dup | 2.75 | Dup | 137.10 | 4.60 | |||||
| Vial | 5.43 | ||||||||||||||
| Residual | 30.56 | ||||||||||||||
Model: lme(betagal_activity ∼ construct, random = list(one1 = pdIdent(∼day-1), one2 = pdIdent(∼line-1), one3 = pdIdent(∼vial-1)), weights = varIdent(form=∼1|construct)). For details, see the legend of Table S1.